CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myelomaGiulia Giorgetti, Michele Cea, Pamela Becherini et al.|Blood Cancer Journal|2025Cited by 3
Higher CD56 Expression on Multiple Myeloma Cells Increases CD38 Expression, Reduces Intracellular NAD+ Levels, and Enhances the Efficacy of Daratumumab-Based Treatment StrategiesGiulia Giorgetti, Michele Cea, Pamela Becherini et al.|Blood|2023Cited by 2